These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 9189040

  • 1. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group.
    Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C.
    Ann Neurol; 1997 Jun; 41(6):789-96. PubMed ID: 9189040
    [Abstract] [Full Text] [Related]

  • 2. Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial.
    Gajdos P, Tranchant C, Clair B, Bolgert F, Eymard B, Stojkovic T, Attarian S, Chevret S, Myasthenia Gravis Clinical Study Group.
    Arch Neurol; 2005 Nov; 62(11):1689-93. PubMed ID: 16286541
    [Abstract] [Full Text] [Related]

  • 3. Treatment of myasthenia gravis acute exacerbations with intravenous immunoglobulin.
    Gajdos P, Chevret S.
    Ann N Y Acad Sci; 2008 Nov; 1132():271-5. PubMed ID: 18096850
    [Abstract] [Full Text] [Related]

  • 4. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis.
    Köhler W, Bucka C, Klingel R.
    J Clin Apher; 2011 Dec; 26(6):347-55. PubMed ID: 22095647
    [Abstract] [Full Text] [Related]

  • 5. [Association of plasmapheresis and high doses of intravenous immunoglobulins in the treatment of myasthenia gravis].
    Tatay J, Díez-Tejedor E, Frank A, Tejada J, Marrero C, Barreiro P.
    Rev Neurol; 1997 Sep; 25(145):1402-6. PubMed ID: 9377299
    [Abstract] [Full Text] [Related]

  • 6. [Fundamental studies with respect to plasma exchange by using continuous-flow centrifuge system and the clinical trial in patients with myasthenia gravis].
    Suga M, Akahonai Y, Tsujisaki M, Mori M, Yoshizaki H, Matsumoto H, Yachi A.
    Hokkaido Igaku Zasshi; 1982 Nov; 57(6):734-40. PubMed ID: 7183499
    [Abstract] [Full Text] [Related]

  • 7. High-dose intravenous immunoglobulin G treatment of myasthenia gravis.
    Ferrero B, Durelli L.
    Neurol Sci; 2002 Apr; 23 Suppl 1():S9-24. PubMed ID: 12032583
    [Abstract] [Full Text] [Related]

  • 8. Intravenous immune globulin in myasthenia gravis.
    Gajdos P.
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
    Jensen P, Bril V.
    J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
    [Abstract] [Full Text] [Related]

  • 10. Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis.
    Qureshi AI, Choudhry MA, Akbar MS, Mohammad Y, Chua HC, Yahia AM, Ulatowski JA, Krendel DA, Leshner RT.
    Neurology; 1999 Feb; 52(3):629-32. PubMed ID: 10025801
    [Abstract] [Full Text] [Related]

  • 11. The treatment of severe forms of myasthenia gravis.
    Iani C, Caramia M, Morosetti M, Loberti M, Palmieri MG, Meloni C, Gallucci MT, Casciani CU, Bernardi G.
    Funct Neurol; 1998 Feb; 13(3):231-7. PubMed ID: 9800150
    [Abstract] [Full Text] [Related]

  • 12. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, Marino M, Bartoccioni E.
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [Abstract] [Full Text] [Related]

  • 13. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.
    Dhawan PS, Goodman BP, Harper CM, Bosch PE, Hoffman-Snyder CR, Wellik KE, Wingerchuk DM, Demaerschalk BM.
    Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838
    [Abstract] [Full Text] [Related]

  • 14. [Plasmapheresis in patients with myasthenia gravis].
    Konishi T.
    Nihon Rinsho; 2008 Jun; 66(6):1165-71. PubMed ID: 18540364
    [Abstract] [Full Text] [Related]

  • 15. High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis.
    Takahashi H, Kawaguchi N, Nemoto Y, Hattori T.
    J Neurol Sci; 2006 Sep 25; 247(2):239-41. PubMed ID: 16876198
    [Abstract] [Full Text] [Related]

  • 16. [Long-term treatment with 7S immunoglobulins in myasthenia gravis. Preliminary clinical results].
    Bamberg C, Janzen RW, Szabados M.
    Nervenarzt; 1996 Apr 25; 67(4):327-32. PubMed ID: 8684513
    [Abstract] [Full Text] [Related]

  • 17. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME, Robson MD, Clover L, Anslow P, Newsom-Davis J, Kennett R, Hilton-Jones D, Matthews PM, Vincent A.
    Brain; 2006 Jun 25; 129(Pt 6):1481-92. PubMed ID: 16672291
    [Abstract] [Full Text] [Related]

  • 18. [Contribution of intravenous immunoglobulins to the treatment of myasthenia].
    Gajdos P.
    Ann Med Interne (Paris); 2000 May 25; 151 Suppl 1():1S30-4. PubMed ID: 10896986
    [Abstract] [Full Text] [Related]

  • 19. IVIG treatment for myasthenia gravis: effectiveness, limitations, and novel therapeutic strategies.
    Zinman L, Bril V.
    Ann N Y Acad Sci; 2008 May 25; 1132():264-70. PubMed ID: 18567877
    [Abstract] [Full Text] [Related]

  • 20. Plasma exchange in myasthenia gravis: electrophysiological studies.
    Campbell WW, Leshner RT, Swift TR.
    Ann Neurol; 1980 Dec 25; 8(6):584-9. PubMed ID: 6260011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.